Literature DB >> 21875732

Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?

Jung Wook Huh1, Chang Hyun Kim, Hyeong Rok Kim, Young Jin Kim.   

Abstract

BACKGROUND: Good responses (ypStage I) after preoperative chemoradiation therapy (CRT) and curative resection for locally advanced rectal cancer are associated with excellent local control and improved disease-free survival. This study was conducted to evaluate whether this population has comparable oncologic outcomes with those for patients with early rectal cancer (pStage I).
METHODS: This prospective study included 123 patients with pathologic stage I rectal cancer that was located less than 7 cm from the anal verge and who underwent radical resection. Of the 123 patients, 30 patients underwent preoperative CRT followed by radical resection, while 93 underwent proctectomy with no preoperative treatment. The oncologic outcomes between the 2 groups were compared.
RESULTS: The median follow-up period was 78 months. The pretreatment clinical staging was significantly different between the 2 groups (P < .001). The 10-year overall and disease-free survival rates for the patients who received preoperative CRT were 48% and 75%, respectively, which were different from the rates for those patients who did not undergo preoperative CRT (83%; P = .001 and 93%; P = .001, respectively); however, the 10-year local recurrence rates did not significantly differ between the patients who received preoperative CRT and those who did not receive preoperative CRT (7% vs 5%, respectively, P = .381).
CONCLUSION: Good responses after preoperative CRT and curative resection for locally advanced rectal cancer may be associated with local control that is similar to that of the patients with early rectal cancer.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21875732     DOI: 10.1016/j.surg.2011.06.018

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.

Authors:  Yuji Toiyama; Yasuhiro Inoue; Mikio Kawamura; Aya Kawamoto; Yoshinaga Okugawa; Jyunichiro Hiro; Susumu Saigusa; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int Surg       Date:  2015-02

2.  Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.

Authors:  Sagar A Patel; Yu-Hui Chen; Jason L Hornick; Paul Catalano; Jonathan A Nowak; Lawrence R Zukerberg; Ronald Bleday; Paul C Shellito; Theodore S Hong; Harvey J Mamon
Journal:  Dis Colon Rectum       Date:  2014-04       Impact factor: 4.585

3.  Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers.

Authors:  Xue Bai; Shiyong Li; Bo Yu; Hong Su; Weisen Jin; Gang Chen; Junfeng DU; Fuyi Zuo
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

4.  Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.

Authors:  Tetsuro Taira; Hiroaki Nozawa; Kazushige Kawai; Kazuhito Sasaki; Koji Murono; Shigenobu Emoto; Junko Kishikawa; Tsuyoshi Ozawa; Yuichiro Yokoyama; Shinya Abe; Yuzo Nagai; Hiroyuki Anzai; Hirofumi Sonoda; Soichiro Ishihara
Journal:  Oncology       Date:  2021-11-24       Impact factor: 2.935

5.  Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent "no tumor" status?

Authors:  Seong-A Jeong; In Ja Park; Seung Mo Hong; Jun Woo Bong; Hye Yoon Choi; Ji Hyun Seo; Hyong Eun Kim; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

6.  Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis.

Authors:  Ignazio Tarantino; Rene Warschkow; Bruno M Schmied; Ulrich Güller; Markus Mieth; Thomas Cerny; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2016-04-11       Impact factor: 3.452

7.  Oncological Outcomes of Pathological T1 Lower Rectal Cancer Patients With or Without Preoperative Chemoradiotherapy.

Authors:  Tetsuro Taira; Hiroaki Nozawa; Kazushige Kawai; Kazuhito Sasaki; Koji Murono; Manabu Kaneko; Shigenobu Emoto; Yuuki Iida; Hiroaki Ishii; Yuichiro Yokoyama; Hiroyuki Anzai; Hirofumi Sonoda; Soichiro Ishihara
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.